Vladimir Todorović
Šifra: 185550
Prezime i ime: Vladimir Todorović
Titula: dr sci med
Zvanje: redovni profesor
Org. jedinica: Medicinski fakultet
Dopunski rad: da
Honorarno: da
Nastava
| Jedinica | Program | Tip | Sem. | Predmet | P x GP | V x GV | L x GL |
|---|---|---|---|---|---|---|---|
| MED | MEDICINA | 3 | OSNOVI KLINIČKE PRAKSE II | .25 x 1 | 0 x 0 | 0 x 0 | |
| MED | MEDICINA | 2 | OSNOVI KLINIČKE PRAKSE I | .29 x 1 | 0 x 0 | 0 x 0 | |
| MED | MEDICINA | 11 | OSNOVI KLINIČKE ONKOLOGIJE | 0 x 0 | 0 x 0 | 0 x 0 | |
| MED | MEDICINA | 2 | OSNOVI ĆELIJSKE BIOLOGIJE | .67 x 1 | 0 x 0 | 0 x 0 | |
| MED | MEDICINA | 2 | OSNOVI MOLEKULARNE GENETIKE | .67 x 1 | 0 x 0 | 0 x 0 | |
| MED | MEDICINA | 5 | VJEŠTINE KOMUNIKACIJE U MEDICINI | .4 x 1 | 0 x 0 | 0 x 0 | |
| MED | MEDICINA | 11 | ONKOLOGIJA | 2 x 1 | 2 x 4 | 0 x 0 |
Izabrane publikacije
| Godina | Kategorija | Autori | Naslov | Izvor |
|---|---|---|---|---|
| 2020 | SCI, SCIE, SSCI, A&HCI | Feng Du, Wenmiao Wang, Yongsheng Wang, Ming Li, Anjie Zhu, Jiayu Wang, Ruigang Cai, Fei Ma, Ying Fan, Qing Li, Pin Zhang, Vladimir Todorovic, Peng Yuan & Binghe Xu | Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer | Breast Cancer Res Treat |
| 2020 | SCI, SCIE, SSCI, A&HCI | Belkacemi Y, Grellier N, Ghith S, Debbi K, Coraggio G, Bounedjar A, Samlali R, Tsoutsou PG, Ozsahin M, Chauvet MP, Turkan S, Boussen H, Kuten A, Tesanovic D, Errihani H, Benna F, Bouzid K, Idbaih A, Mokhtari K, Popovic L, Spano JP, Lotz JP, Cherif A, To H, Kovcin V, Arsovski O, Beslija S, Dzodic R, Markovic I, Vasovic S, Stamatovic L, Radosavljevic D, Radulovic S, Vrbanec D, Sahraoui S, Vasev N, Stojkovski I, Risteski M, Freixa SV, Krengli M, Radosevic N, Mustacchi G, Filipovic M, Kerrou K, Taghian AG, Todorovic V, Geara F, Gligorov J. | 1. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. | Eur J Cancer |
| 2019 | SCI, SCIE, SSCI, A&HCI | Todorovic V, Aapro M, Pavlidis N, Arsovski O, Belkacemi Y, Babovic N, Bidard FC, Bourhafour M, Beslija S, Boussen H, Cetnikovic B, Ceric T, Cicmil N, Crnogorac N, Cuedari E, De Laurentis M, Dragovich T, Durutovic I, Dzamic Z, Dzodic R, Eri Z, Geara F, Khalil A, Kerrou K, Knezevic Usaj S, Kovcin V, Koroveshi D, Kristo Pema A, Kuten A, Lakicevic J, Lukovac N, Markovic I, Markovic M, Mijalkovic N, Miladinova D, Milasevic N, Mustachi G, Ognjenovic D, Pantelic A, Popovic L, Radosavljevic D, Radosevic N, Radulovic S, Ristevski M, Rosic I, Secen N, Sorat M, Stamatovic L, Stefanovski P, Stojkovski I, Tesanovic D, Tomasevic Z, Tomasevic Z, Tsoutsou P, Turkan S, Vasev N, Vasovic S, Vicko F, Vrbanec D, Vukmirovic F, Vrdoljak E, Zaric B, Zambrovski JJ, Cavalli F, Gligorov J. | AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan). | J BUON |
| 2019 | SCI, SCIE, SSCI, A&HCI | EDUARD VRDOLJAK, GYORGY BODOKY, JACEK JASSEM, RAZVAN POPESCU, ROBERT PIRKER, TANJA ČUFER, SEMIR BEŠLIJA, ALEXANDRU ENIU, VLADIMIR TODOROVIĆ, KATERINA KOPEcKOVÁ, GALIA KURTEVA, ZORICA TOMAŠEVIĆ, AGIM SALLAKU, SNEZHANA SMICHKOSKA, ŽARKO BAJIĆ, BRANIMIR SIKIC | Expenditures on Oncology Drugs and Cancer Mortality-to- Incidence Ratio in Central and Eastern Europe | Oncologist |
| 2017 | SCI, SCIE, SSCI, A&HCI | Vladimir Todorovic, Nada Cicmil Saric, Jadranka Lakicevic, Milan Sorat | Evaluation of safety of bevacizumab as second-line treatment of patients with metastatic colorectal cancer | JOURNAL OF BUON |
| 2017 | SCI, SCIE, SSCI, A&HCI | Gligorov J, Richard S, Todorovic V | New anti-HER2 agents: from second-generation tyrosine kinases inhibitors to bifunctional antibodies | Curr Opin Oncol |
| 2017 | SCI, SCIE, SSCI, A&HCI | Kandolf Sekulovic L, Peris K, Hauschild A, Stratigos A, Grob JJ, Nathan P, Dummer R, Forsea AM, Hoeller C, Gogas H, Demidov L, Lebbe C, Blank C, Olah J, Bastholt L, Herceg D, Neyns B, Vieira R, Hansson J, Rutkowski P, Krajsova I, Bylaite-Bucinskiene M, Zalaudek I, Maric-Brozic J, Babovic N, Banjin M, Putnik K, Weinlich G, Todorovic V, Kirov K, Ocvirk J, Zhukavets A, Kukushkina M, De La Cruz Merino L, Ymeri A, Risteski M, Garbe C | More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments | Eur J Cancer |
| 2016 | SCI, SCIE, SSCI, A&HCI | Vrdoljak E, Bodoky G, Jassem J, Popescu RA, Mardiak J, Pirker R, Čufer T, Bešlija S, Eniu A, Todorović V, Kubáčková K, Kurteva G, Tomašević Z, Sallaku A, Smichkoska S, Bajić Ž, Šikić BI | Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement | Oncologist |
| 2014 | SCI, SCIE, SSCI, A&HCI | Todorović, V., Damjanović, S. & Lukovac Janjić, N. | Targeted therapy in metastatic hereditary Paragangliomas | Mitteilungen Klosterneuburg |
| 2014 | SCI, SCIE, SSCI, A&HCI | Todorović, V. | Prevention and management of stomatitis during treatment with Everolimus | Wulfenia |
| 2011 | SCI, SCIE, SSCI, A&HCI | Vrdoljak, E., Wojtukiewicz, MZ., Pienkowski, T., Bodoky, G., Berzinec, P., Finek, J., Todorović, V., Borojević, N., Croitoru, A. & South Eastern European Research Oncology Group | Cancer epidemiology in Central and South Eastern European countries | Croatian Medical Journal |
© 2017 UCG -
Univerzitet Crne Gore. Sva prava zadržana.